Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01321437
Title Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, Irvine
Indications

melanoma

Therapies

Axitinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.